MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ckj/sfad280

Медицинская библиотека · Clinical kidney journal · 2023

Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis.

Takkavatakarn Kullaya, Jintanapramote Kavita, Phannajit Jeerath, Praditpornsilpa Kearkiat, Eiam-Ong Somchai, Susantitaphong Paweena

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Appropriate dialysis prescription in the transitional setting from chronic kidney disease to end-stage kidney disease is still challenging. Conventional thrice-weekly haemodialysis (HD) might be associated with rapid loss of residual kidney function (RKF) and high mortality. The benefits and risks of incremental HD compared with conventional HD were explored in this systematic review and meta-analysis.

METHODS

We searched MEDLINE, Scopus and Cochrane Central Register of Controlled Trials up to April 2023 for studies that compared the impacts of incremental (once- or twice-weekly HD) and conventional thrice-weekly HD on cardiovascular events, RKF, vascular access complications, quality of life, hospitalization and mortality.

RESULTS

A total of 36 articles (138 939 participants) were included in this meta-analysis. The mortality rate and cardiovascular events were similar between incremental and conventional HD {odds ratio [OR] 0.87 [95% confidence interval (CI)] 0.72-1.04 and OR 0.67 [95% CI 0.43-1.05], respectively}. However, hospitalization and loss of RKF were significantly lower in patients treated with incremental HD [OR 0.44 (95% CI 0.27-0.72) and OR 0.31 (95% CI 0.25-0.39), respectively]. In a sensitivity analysis that included studies restricted to those with RKF or urine output criteria, incremental HD had significantly lower cardiovascular events [OR 0.22 (95% CI 0.08-0.63)] and mortality [OR 0.54 (95% CI 0.37-0.79)]. Vascular access complications, hyperkalaemia and volume overload were not statistically different between groups.

CONCLUSIONS

Incremental HD has been shown to be safe and may provide superior benefits in clinical outcomes, particularly in appropriately selected patients. Large-scale randomized controlled trials are required to confirm these potential advantages.

Для цитирования: Takkavatakarn Kullaya, Jintanapramote Kavita, Phannajit Jeerath, Praditpornsilpa Kearkiat, Eiam-Ong Somchai, Susantitaphong Paweena. Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis.. Clinical kidney journal. 2023. DOI: 10.1093/ckj/sfad280.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.